首页> 美国卫生研究院文献>American Health Drug Benefits >Analysis of Stakeholder Engagement in the Public Comments of ICER Draft Evidence Reports
【2h】

Analysis of Stakeholder Engagement in the Public Comments of ICER Draft Evidence Reports

机译:分析利益攸关方参与公用语发表报告报告报告报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Health technology assessment is becoming increasingly important to healthcare payers' decision-making. The Institute for Clinical and Economic Review (ICER) is the most established US-based research group performing value assessments. ICER provides opportunities for stakeholder engagement, including a window of opportunity for public comments on the draft evidence report. Those public comments were reviewed in this study.
机译:健康技术评估对医疗工作者的决策越来越重要。临床和经济审查研究所(ICER)是最成熟的基于美国的研究小组进行了价值评估。 ICER为利益相关者参与提供了机会,包括关于对证据草案报告草案的公众意见的机会窗口。本研究审查了这些公众意见。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号